Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1409]

Carboplatin & paclitaxel chemotherapy alone should remain standard treatment for endometrial cancer

Carboplatin & paclitaxel chemotherapy alone should remain standard treatment for endometrial cancer

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival

A 'one-two punch' to wipe out cancerous ovarian cells

A 'one-two punch' to wipe out cancerous ovarian cells

ASCO 2019: New standard regimen for women with uterine carcinosarcomas

ASCO 2019: New standard regimen for women with uterine carcinosarcomas

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

ASCO 2019: Earlier ovarian cancer diagnoses and treatment seen after ACA implementation

ASCO 2019: Earlier ovarian cancer diagnoses and treatment seen after ACA implementation

ASCO 2019: Drug targeting DNA damage response shows promise against cancers of anus and genitals

ASCO 2019: Drug targeting DNA damage response shows promise against cancers of anus and genitals

ASCO 2019: Patient groups untested in cancer immunotherapy trials found to also benefit

ASCO 2019: Patient groups untested in cancer immunotherapy trials found to also benefit

Women in developing countries need radiotherapy and vaccines for cervical cancer

Women in developing countries need radiotherapy and vaccines for cervical cancer

Summer School in Translational Cancer Research, Algarve, Portugal, October 7-11, 2019

Summer School in Translational Cancer Research, Algarve, Portugal, October 7-11, 2019

More from ecancer